After four days of culture, the percentage of surviving cells in the cultures treated with anti-ITGA6 or anti-ITGB4 antibodies were significantly reduced in the two EVI1 and primary AML cell lines compared with the control cells (Figs. 5A to D). Here, RUNX1 is linked to acute myeloid leukemia.